« back to reports
Digital Health Report

Q1 2023

Digital Health Report

June 16, 2023

Fill out the form to download a preview of this report. The full report is available through the PitchBook Platform.

Are we in the age of Ozempic?

Weight loss drugs such as Wegovy, Ozempic, and Mounjaro have exploded onto the digital health scene, and companies and investors are looking to cash in. But behind the glossy ads, the drugs come with potential side effects, patient risks, and high price tags.

Is this VC’s latest fad or a lasting transformation to healthcare? Our Q1 2023 Digital Health Report digs deep into this trend and others in a precarious time for an industry where exits have almost entirely come to a standstill.

Table of contents
Vertical update 3
Q1 2023 timeline 4
Digital health landscape 5
Digital health VC ecosystem market map 6
VC activity 8
Emerging opportunities 14
       Weight loss management 15
        Telehealth shift from DTC to B2B 17
Select company highlights 19
       Monogram Health 20
       Papa 23
       Headspace Health 26